Earnings per Share
(In millions except per share amounts)202320222021
Net income attributable to Thermo Fisher Scientific Inc.
$5,995 $6,950 $7,725 
Basic weighted average shares
386 392 394 
Plus effect of: stock options and restricted stock units
Diluted weighted average shares
388 394 397 
Basic earnings per share
$15.52 $17.75 $19.62 
Diluted earnings per share
$15.45 $17.63 $19.46 
Antidilutive stock options excluded from diluted weighted average shares

Historical Timeline

Fiscal YearFiled
2023Feb 22, 2024Showing above
2022Feb 23, 2023
2021Feb 24, 2022
2020Feb 25, 2021
2019Feb 26, 2020
2018Feb 27, 2019
2017Feb 28, 2018
2016Feb 28, 2017
2015Feb 25, 2016

About Earnings Per Share Disclosures

The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.

Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.